Organon & Co
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +7.8% | -25.0% | -21.0% | +12.4% | -65.1% | -6.9% | +17.5% | -25.5% | |
| – | -15.2% | -80.1% | -57.4% | +37.3% | +8.7% | +11.3% | +17.4% | +30.3% | |
| – | +0.0% | -26.8% | -2.4% | +47.5% | +27.1% | +34.7% | +4.0% | -26.7% | |
| – | -96.9% | +205.7% | -37.4% | +213.4% | -13.8% | – | – | – | |
| – | – | – | – | – | -164.4% | – | – | – | |
| – | +17.4% | -8.9% | +202.2% | +75.5% | -12.5% | -38.9% | +34.5% | -53.8% | |
| – | +23.2% | +47.8% | +152.9% | +86.4% | -12.7% | -38.1% | +97.3% | -24.0% | |
| – | – | +0.0% | +0.0% | +0.0% | +100.0% | +1.4% | +1.0% | -70.4% | |
| – | – | – | – | – | – | +54.5% | +29.4% | – | |
| – | – | -174.6% | – | +563.3% | -101.4% | +138.9% | -95.7% | +4,063.6% | |
| – | +23.5% | -37.1% | -17.0% | -38.7% | -67.5% | +31.4% | -35.3% | +52.4% | |
| – | – | – | -432.0% | – | -104.6% | – | – | – | |
| – | +7.6% | -25.4% | -28.6% | +3.2% | -78.1% | +24.8% | +9.3% | -8.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.